High Purity XCE Tirzepatide CAS 2023788-19-2 - Bulk Supply for Laboratory Research

XCE Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research applications. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.

The molecular structure of XCE Tirzepatide features greater affinity for GIP receptors while maintaining significant activity at GLP-1 receptors. This unique dual mechanism has shown promising results in reducing hyperglycemia in research settings. The compound mimics the actions of natural GIP at the GIP receptor while simultaneously activating GLP-1 pathways.

Our XCE Tirzepatide is supplied as a white lyophilized powder with purity exceeding 98% as verified by HPLC analysis. The product is carefully packaged to ensure stability during transport and storage. For research purposes only, not intended for human consumption.

Key research applications include investigation of metabolic pathways, diabetes mechanisms, and potential therapeutic approaches for glucose regulation. The dual receptor activity makes XCE Tirzepatide particularly valuable for comparative studies with single-pathway agonists.